Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqCM:LWLG
NasdaqCM:LWLGElectronic

Will New Omnibus Shelf Registration Expand Lightwave Logic's (LWLG) Strategic Financing Options and Narrative?

In June 2026, Lightwave Logic, Inc. filed an omnibus shelf registration covering common stock, preferred stock, warrants, and units, giving it the flexibility to issue these securities over time. This broad shelf registration is material because it expands the company’s options for future capital raising without committing to a specific financing transaction today. Next, we’ll examine how this expanded capital-raising flexibility shapes Lightwave Logic’s investment narrative and what it...
NYSE:FITB.PRA
NYSE:FITB.PRABanks

3 US Financial Stocks With Rate Sensitivity And Fair Value Gaps

With inflation pressures still in focus and the Federal Reserve keeping a firm tone on interest rates, financial stocks are back under the spotlight. Higher-for-longer policy settings can reshape funding costs, loan demand, and investment income for banks and insurance companies, but the impact is far from uniform. Some stocks from our Financials screener appear better positioned for this backdrop, while others may face more of a grind. This article unpacks three stocks from that list, all...
TSX:CVE
TSX:CVEOil and Gas

How Gas-Weighted Assets And LNG Exposure At Cenovus Energy (TSX:CVE) Have Changed Its Investment Story

Cenovus Energy has been highlighted as having gas-rich conventional and offshore assets, with natural gas and natural gas liquids making up most of its production in these areas, positioning it to benefit from growing global liquefied natural gas demand. This emphasis on gas-weighted assets across Canada and Asia-Pacific adds an extra layer of diversification that could influence how investors view Cenovus’s long-term energy mix and earnings profile. We’ll now examine how Cenovus’s...
NasdaqGS:PANW
NasdaqGS:PANWSoftware

Palo Alto Networks (PANW) Stock Could Be 82.8% Overvalued After AI Security Momentum

Recent commentary on Palo Alto Networks (PANW) centers on how quickly and profitably the company has integrated major acquisitions, while its three-platform, AI-focused security offering gains attention as AI-driven cyber threats intensify. See our latest analysis for Palo Alto Networks. Palo Alto Networks’ recent acquisition updates and AI-focused product momentum sit alongside very strong share price performance, with a 90 day share price return of 82.18% and a 5 year total shareholder...
NYSE:TNC
NYSE:TNCMachinery

Tennant (TNC) Stock Could Be 7.6% Overvalued After Rusty Zay COO Appointment

Tennant stock reacts to COO appointment of Rusty Zay Tennant (TNC) stock is in focus after the company appointed Richard H. "Rusty" Zay as Chief Operating Officer, effective July 1, 2026, expanding his responsibilities across core global operations. See our latest analysis for Tennant. The appointment of Rusty Zay as COO comes as Tennant shares trade at $90.15, with a 90 day share price return of 33.67% and a 1 year total shareholder return of 19.69%. This suggests recent momentum has been...
NasdaqGS:NSSC
NasdaqGS:NSSCElectronic

Napco Security Technologies (NSSC) Stock Could Be 25.5% Undervalued After Institutional Buying

Napco Security Technologies (NSSC) is back in focus after fresh data showed institutional ownership rising to 104.53%, alongside improved financial health backed by higher annual revenue and more than doubled net income. See our latest analysis for Napco Security Technologies. The share price of Napco Security Technologies has eased around 12% over the past three months and is down about 9% year to date. However, the 1 year total shareholder return of roughly 38% and 5 year total shareholder...
NYSE:SQM
NYSE:SQMChemicals

Sociedad Química y Minera de Chile (NYSE:SQM) Stock Could Be 4% Overvalued On Lithium Recovery Hopes

Recent Performance Snapshot Sociedad Química y Minera de Chile (SQM) has drawn renewed investor attention after a period of mixed share performance, with the stock down 1.3% on the day and modestly negative over the past week. Over the past month the stock is down 1.9%, while the past 3 months show a gain of 2.2%. Year to date, the share price is up 12.8%, and the reported 1 year total return stands at 140.7%. See our latest analysis for Sociedad Química y Minera de Chile. At a share price of...
NYSE:HHH
NYSE:HHHReal Estate

How a Blowout Quarter and Vantage’s Long-Duration Earnings At Howard Hughes Holdings (HHH) Has Changed Its Investment Story

In the most recent quarter, Howard Hughes Holdings reported revenues of US$235.9 million, up 18.4% year on year, and significantly exceeded analysts’ expectations for both revenue and EPS. CEO David R. O’Reilly called 2026 a pivotal year, highlighting strong land sales, healthy home demand, leasing growth, and new long-duration earnings from Vantage as key drivers of the company’s momentum. Next, we’ll examine how this stronger-than-expected quarter and the emphasis on long-duration Vantage...
ASX:AMI
ASX:AMIMetals and Mining

ASX Growth Stocks Insiders Are Investing In

As the Australian market anticipates a 20-point advance at open, buoyed by global optimism and recent diplomatic progress, investors are keeping a close watch on economic indicators like the S&P Global’s Australia June composite PMI data for further insights. In this climate of cautious optimism, growth companies with high insider ownership can be particularly appealing to investors seeking stocks that insiders have confidence in, as these insiders often possess valuable insights into their...
ASX:LOV
ASX:LOVSpecialty Retail

ASX June 2026 Stocks Possibly Trading Below Fair Value Estimates

As the Australian market braces for potential fluctuations amidst global optimism and local uncertainties, investors are keenly observing developments that could impact stock valuations. In this environment, identifying stocks that may be trading below their fair value estimates can provide opportunities for those looking to capitalize on potential mispricings in the market.
ASX:OEC
ASX:OECAerospace & Defense

ASX Penny Stocks: Immutep And Two More Companies To Watch

The Australian market is poised for a 20-point advance at open, reflecting global optimism despite recent tech sector jitters overseas. While the term 'penny stocks' might seem outdated, these smaller or newer companies still hold significant potential when supported by strong financials. In this article, we explore three promising penny stocks that combine balance sheet strength with growth opportunities, offering investors a chance to uncover hidden value in quality companies.
TSE:8984
TSE:8984REITs

Daiwa House REIT Investment (TSE:8984) Stock Could Face Fair Value Questions After Dividend Cut

Daiwa House REIT Investment (TSE:8984) recently announced a semi annual dividend of ¥2,483 per share, payable on November 10, 2026, with an ex dividend date of August 28 and a record date of August 31. See our latest analysis for Daiwa House REIT Investment. The dividend reduction lands at a time when Daiwa House REIT Investment’s share price has fallen 17.31% year to date and 8.28% over the past 90 days. Its 1 year total shareholder return, which includes distributions, is 2.62%, pointing to...
NYSE:BRK.A
NYSE:BRK.ADiversified Financial

Berkshire Hathaway (BRK.A) Makes Its First Big Portfolio Move Under Greg Abel

Berkshire Hathaway (NYSE:BRK.A), under new CEO Greg Abel, has opened fresh positions in the New York Times, Macy's, and Delta Air Lines. This is the first major reshuffle of Berkshire's equity portfolio since the leadership transition from Warren Buffett. The new holdings increase the company's exposure to media and retail alongside its existing mix of businesses and investments. Berkshire Hathaway enters this shift with its A shares last closing at $734,399.99. Over the past 3 years the...
NasdaqCM:ONDS
NasdaqCM:ONDSCommunications

Ondas (ONDS) Stock Could Be 54.4% Undervalued After $150 Million Defense Order Quarter

Ondas (ONDS) is back in focus after securing over US$40 million in new autonomous defense orders in June, pushing total second quarter order activity above US$150 million and directly connecting that to new defense trials and partnerships. See our latest analysis for Ondas. Despite the new defense orders, Ondas’ share price is down 19.33% year to date and 16.76% over the past 90 days, while its 1 year total shareholder return is very large, indicating long term momentum even as short term...
NasdaqGM:ORKA
NasdaqGM:ORKABiotechs

Oruka Therapeutics (ORKA) Is Up 5.1% After Positive Trial Update And Insider Share Sales - What's Changed

Earlier this week, Oruka Therapeutics reported highly positive progress in its clinical trial pipeline for monoclonal antibody treatments targeting psoriasis and other inflammatory conditions, alongside insider share sales by its Senior Vice President of Finance under a pre-arranged Rule 10b5-1 plan. The combination of encouraging clinical advancement, a substantial cash position with no long-term debt, and intense momentum trading interest has sharpened attention on Oruka’s high-risk,...
NYSE:HCC
NYSE:HCCMetals and Mining

Warrior Met Coal’s (HCC) Insider Sales Amid Rich Valuation: What Do They Signal About Risk‑Reward?

Recently, Warrior Met Coal was flagged as trading well above one intrinsic value estimate while insiders sold about US$2.2 million of stock over three months without any offsetting insider purchases. This tension between strong recent financial results and rising institutional ownership on one hand, and valuation plus insider selling concerns on the other, raises fresh questions about how investors assess the company’s risk‑reward profile today. We’ll now examine how insider selling amid...
LSE:GAMA
LSE:GAMATelecom

3 Canadian Dividend Stocks With Defensive Cash Flows And Yield

With tech heavy indices under pressure after the SpaceX sell off, sector wide weakness in AI and chip stocks, and fresh inflation worries from the Iran war and Strait of Hormuz disruption, many investors are looking at defensive dividend stocks as a potential anchor for their portfolios. This article focuses on three income focused stocks from our Defensive Dividend Stocks screener that appear closely exposed to the current news backdrop. Each offers a dividend yield above 1.5% and sits in...
BSE:500470
BSE:500470Metals and Mining

3 UK Metals And Steel Stocks Facing Audit Risk

Regulators have just put UK metals and steel audits under a harsh spotlight, and that kind of scrutiny can quickly shift how investors view risk. The King & King ruling, tied to Sanjeev Gupta’s GFG Alliance companies, raises fresh questions about audit quality, fee dependence and the reliability of financial statements across parts of the sector. For anyone holding or considering exposure to these stocks, this is a moment to reassess where audit risk might sit in a portfolio. This article...
NasdaqGM:ADMA
NasdaqGM:ADMABiotechs

Is Securities Fraud Litigation Over Reported ASCENIV Sales Altering The Investment Case For ADMA Biologics (ADMA)?

In recent months, multiple law firms have filed federal securities class action lawsuits against ADMA Biologics, alleging channel stuffing, undisclosed related-party transactions, and weak internal controls between August 9, 2024 and March 25, 2026. The suits, many prompted by a short-seller report, now center on whether ADMA’s reported ASCENIV revenue and governance practices accurately reflected its true commercial performance. We’ll now examine how these securities fraud allegations and...
NYSE:WELL
NYSE:WELLHealth Care REITs

Welltower (WELL) Stock Could Be 7.3% Undervalued After Its Planned Dividend Raise

Dividend move puts Welltower in focus for income investors Welltower (WELL) has drawn fresh attention after announcing that it expects to raise its quarterly common stock dividend to $0.85 per share starting with the second quarter of 2026, a key development for income focused investors. See our latest analysis for Welltower. Welltower’s share price has climbed 13.11% year to date and its 1 year total shareholder return of 39.31% points to building momentum, underpinned by dividend plans,...
NasdaqGS:ROKU
NasdaqGS:ROKUEntertainment

Roku (ROKU) Stock Could Be 7.4% Undervalued After Recent Pullback

Roku (ROKU) is back in focus after recent share price swings, prompting investors to reassess how its TV streaming platform, device sales and advertising driven platform revenue fit into their broader portfolios. See our latest analysis for Roku. Roku’s recent pullback, with the 1-day share price return down 2.08% and 7-day share price return down 4.05%, comes after a strong run that includes a 30-day share price return of 7.69%, a 90-day share price return of 41.44% and a 1-year total...
NasdaqGS:CSWC
NasdaqGS:CSWCCapital Markets

Capital Southwest (CSWC) Stock Could Be 6.8% Undervalued After Q4 Results And New Venture

Capital Southwest (CSWC) is back in focus after reporting fiscal Q4 and full-year 2026 results, highlighting a larger investment portfolio, higher profitability, and a new $100 million joint venture with Trinity Capital. See our latest analysis for Capital Southwest. At a share price of $23.20, Capital Southwest has delivered a 90 day share price return of 5.89% and a 1 year total shareholder return of 22.47%. This points to steady, income led momentum rather than a sharp re rating. If this...
NYSE:BLK
NYSE:BLKCapital Markets

3 US Stocks Tied To Social Security Reform And Low P E

Social Security reform is back in the headlines, and this time the idea on the table is a proposed $1.5 trillion investment fund that would put government money into U.S. stocks. That kind of steady buyer could reshape demand for equity managers, index trackers and ETF providers, even as questions around borrowing, political support and timing keep uncertainty high. For you as an investor, the interest lies in which stocks sit closest to this potential flow of public money. This article...
TSE:4502
TSE:4502Pharmaceuticals

How Phase 3 Wins In Narcolepsy And Psoriasis At Takeda Pharmaceutical (TSE:4502) Have Changed Its Investment Story

Takeda Pharmaceutical recently reported additional Phase 3 data at SLEEP 2026 showing its investigational orexin agonist oveporexton improved daily functioning, cognition and nighttime sleep in narcolepsy type 1, while the FDA is reviewing its New Drug Application under Priority Review with a PDUFA decision expected in the third quarter of this year. In parallel, Takeda announced that its oral TYK2 inhibitor zasocitinib achieved superior complete skin clearance and other efficacy endpoints...